| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2019 | 1,003.00 | 1,037.00 | 999.00 | 1,033.00 | 309,154 |
| May 16, 2019 | 1,060.00 | 1,060.00 | 992.50 | 998.00 | 208,308 |
| May 15, 2019 | 1,011.00 | 1,016.00 | 988.00 | 1,014.00 | 204,689 |
| May 14, 2019 | 993.50 | 996.50 | 985.00 | 989.50 | 138,319 |
| May 13, 2019 | 990.00 | 997.00 | 977.00 | 982.50 | 86,656 |
| Name | Clinigen Group | Epic | CLIN |
|---|---|---|---|
| ISIN | GB00B89J2419 | Currency | GBX |
| Type | Equity | Trading Segment | AMSM |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Biotechnology |
| EMS | 2,000 | Prev Close | 1,033.00 |
| Shares in Issue (m) | 132.43 | Market Cap (£m) | 1,321.68 |
| PE Ratio | 43.58 | Div per Share (p) | 5.60 |
| Div Yield | 0.00 | Div Cover | 4.09 |
| EPS | 22.90 | EPS Growth (%) | 593.94 |
| PEG | 0.07 | DPS Growth (%) | 12.00 |
| ROCE | 6.49 | Net Gearing | 42.17 |
| Quick Ratio | 1.16 | Current Ratio | 1.35 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 15 May | Peel Hunt | Buy | 1,033.00 | 1,390.00 | - | Reiterates |
| 02 Apr | Peel Hunt | Buy | 1,033.00 | 1,390.00 | - | Reiterates |
| 27 Mar | Peel Hunt | Buy | 1,033.00 | 1,390.00 | - | Reiterates |
| 12 Mar | Peel Hunt | Buy | 1,033.00 | 1,390.00 | - | Reiterates |
| 27 Feb | RBC Capital Markets | Top pick | 1,033.00 | 1,470.00 | 1,640.00 | Unchanged |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 01 Oct 2018 | Shaun Chilton | Placing | 7,101 @ 845.00p | £60,003.45 |
| 01 Oct 2018 | Anne Hyland | Placing | 4,142 @ 845.00p | £34,999.90 |
| 24 Nov 2017 | Chris Rigg | Sell | 4,955 @ 1,017.00p | £50,392.35 |
| 16 Oct 2017 | Shaun Chilton | Sell | 100,000 @ 1,150.00p | £1,150,000.00 |
| 03 Oct 2017 | John Bacon | Sell | 250,000 @ 1,092.96p | £2,732,400.00 |
